Health Care: Drugs

Pacific Biosciences of California Inc (PACB: NASDAQ)

$4.75 n/a | n/a%
07/25/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 4.75
52 Week High 8.20
52 Week Low 2.54
Avg. Daily Vol. (Mil) 0.68
Beta (3 year) 2.51
Share Related Items
Mkt Cap (Mil) 334.85
Shares Out (Mil) 70.50
Float (Mil) 51.35
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.40
Current Ratio 5.90
LT Debt/ Equity 0.21
Total Debt / Equity 0.21
Valuation Ratios
Price Earnings n.a.
Price/Sales 8.45
Price/Book 4.43
Price/Cash Flow -4.70
Per Share Data
Earnings -1.12
Sales 0.56
Book Value 1.07
Cash Flow -1.01
Business Summary
Pacific Biosciences of California, Inc., is engaged in design, development and commercialization of innovative tools for biological research. The Company's products include the SMRT Cell, Phospholinked nucleotides, the PacBio RS.
General Information
1380 Willow Road
Menlo Park, CA 94025
www.pacificbiosciences.com
Industry : Drugs
Sector: Health Care
Employees: 318
CEO: Michael W. Hunkapiller
Short Interest
Current Month (Mil) 7.23
Previous Month (Mil) 7.19
Short Interest Ratio (Days) 10.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -54.60
Return on Investments -84.30
Profitability
Gross Margin 41.80
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with PACB

Latest PACB Headlines from TheStreet

More Financial News for PACB

Press Releases for PACB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter